Program GoalsClick here to register for this event
This program is designed to improve clinical awareness of spinal muscular atrophy (SMA), the leading inherited cause of infant mortality. Historical and updated findings concerning the syndrome and the causative recessive gene survival of motor neuron (SMN1) will be presented. The potential influence that SMN2 has on the severity of the disease progression will also be discussed. Carrier testing and prenatal diagnosis will be discussed along with considerations for population carrier screening.
Obstetricians/Gynecologists, Ph.D. Clinical Geneticists, M.D. Medical Geneticists, Genetic Counselors, Pediatricians, Nurses, Mental Health Specialists, Laboratory Professionals, and related healthcare professionals interested or involved in the clinical relevance of spinal muscular atrophy.
Upon completion of this activity, participants should be able to:
Kathryn J. Swoboda, MD
Educational Activity Agenda
- 01 minutes: Welcome & Introduction
Global Education Group adheres to the ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships as well as the discussion of unlabeled/investigational use of any drug, device or procedure by the faculty, are made known below.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse / life partner have with commercial interests related to the content of this P.A.C.E. accredited activity:
Disclosure of Unlabeled Use / Investigational Use
In this activity, the following faculty discloses that they may discuss the unlabeled or investigational use of drugs, devices or procedures in their discussions regarding hepatitis therapy:
• Kathryn J. Swoboda, MD
Planners and Managers
Employees of Global Education Group, the accredited provider for this activity, have disclosed that they have no significant financial relationships.
Employees of Dane Garvin Ltd., the joint sponsor for this activity, have disclosed they have no significant financial relationships.
CME (ACCME) Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and Dane Garvin Ltd. (DGL). Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation - Physician, CME
Global Education Group designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
How to Obtain CME Credit
ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED
Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.0 AMA PRA Category 1 Credit(s)™. To receive credit, the course must be completed before September 15, 2009.
Credit Designation - Lab Professional, P.A.C.E.®
The American Society for Clinical Laboratory Sciences Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.0 contact hour of credit.
How to Obtain P.A.C.E.® Credit
ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED
Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before September 15, 2009.
Participants who have already received P.A.C.E.® credit for attending the July 28, 2008 live webcast are not eligible to receive additional credit for this enduring online activity.
Should you have any P.A.C.E.® questions regarding this activity, please contact:
For technical difficulties, please consult our Technical Instructions.
Release and Expiration
Release Date: September 15, 2008
There is no fee for this educational activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Global Education Group and/or Dane Garvin, Ltd. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Global Education Group and Dane Garvin, Ltd. do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.
Policy on Privacy and Confidentiality
Global Education Group (Global) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
This program has been made available online.
"Spinal Muscular Atrophy"
Commercial Support Statement
This activity is supported by an educational grant from Genzyme, Inc.
Copyright © September 15, 2008 – September 15, 2009. Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation is granted to Global Education Group (Global) and American Society for Clinical Laboratory Sciences.